Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Deep Track Capital, LP | Institution | 3.600.000 | 8,37% | US$ 206,68M | 2026-03-31 |
| BlackRock, Inc. | Institution | 3.552.612 | 8,26% | US$ 203,96M | 2026-03-31 |
| RTW Investments, LP | Institution | 3.346.025 | 7,78% | US$ 192,10M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 3.000.000 | 6,97% | US$ 172,23M | 2025-09-30 |
| Paradigm Biocapital Advisors LP | Institution | 2.562.154 | 5,96% | US$ 147,09M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 2.240.963 | 5,21% | US$ 128,65M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 2.094.428 | 4,87% | US$ 120,24M | 2024-09-30 |
| Morgan Stanley | Institution | 1.868.677 | 4,34% | US$ 107,28M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1.760.541 | 4,09% | US$ 101,07M | 2026-03-31 |
| Jennison Associates LLC | Institution | 1.712.124 | 3,98% | US$ 98,29M | 2026-03-31 |
| Frazier Life Sciences IX, L.P. | Institution | 1.587.527 | 3,69% | US$ 91,14M | 2024-09-30 |
| Assenagon Asset Management S.A. | Institution | 1.280.194 | 2,98% | US$ 73,50M | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 1.188.624 | 2,76% | US$ 68,24M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.121.091 | 2,61% | US$ 64,36M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 978.212 | 2,27% | US$ 56,16M | 2026-03-31 |
| Bank of America Corporation | Institution | 948.071 | 2,20% | US$ 54,43M | 2026-03-31 |
| Driehaus Capital Management LLC | Institution | 926.125 | 2,15% | US$ 53,17M | 2026-03-31 |
| Dr. Bobak Azamian | Insider | 891.412 | 2,07% | US$ 51,18M | 2026-03-19 |
| Lord, Abbett & Co. LLC | Institution | 842.313 | 1,96% | US$ 48,36M | 2026-03-31 |
| Medical Strategy GmbH | Institution | 821.962 | 1,91% | US$ 47,19M | 2025-12-31 |
| D. E. Shaw & Co., L.P. | Institution | 791.146 | 1,84% | US$ 45,42M | 2026-03-31 |
| Tang Capital Partners International, LP | Institution | 784.938 | 1,82% | US$ 45,06M | 2025-12-31 |
| FMR LLC | Institution | 733.270 | 1,70% | US$ 42,10M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 728.644 | 1,69% | US$ 41,83M | 2026-03-31 |
| Cowen Inc. | Institution | 617.583 | 1,44% | US$ 35,46M | 2025-09-30 |
| Invesco Ltd. | Institution | 570.110 | 1,33% | US$ 32,73M | 2026-03-31 |
| Millennium Management LLC | Institution | 564.579 | 1,31% | US$ 32,41M | 2026-03-31 |
| ClearBridge Investments, LLC | Institution | 545.351 | 1,27% | US$ 31,31M | 2026-03-31 |
| The Toronto-Dominion Bank | Institution | 510.253 | 1,19% | US$ 29,29M | 2026-03-31 |
| Nomura Investment Management Business Trust | Institution | 499.853 | 1,16% | US$ 28,70M | 2026-03-31 |
| Loomis Sayles & Company, L.P. | Institution | 407.836 | 0,95% | US$ 23,41M | 2026-03-31 |
| TimesSquare Capital Management, LLC | Institution | 388.590 | 0,90% | US$ 22,31M | 2026-03-31 |
| Tang Capital Partners, LP | Institution | 360.186 | 0,84% | US$ 20,68M | 2025-12-31 |
| Northern Trust Global Investments | Institution | 352.957 | 0,82% | US$ 20,26M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 335.889 | 0,78% | US$ 19,28M | 2026-03-31 |
| Ensign Peak Advisors, Inc. | Institution | 332.982 | 0,77% | US$ 19,12M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 329.750 | 0,77% | US$ 18,93M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 328.162 | 0,76% | US$ 18,84M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 324.014 | 0,75% | US$ 18,60M | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 307.307 | 0,71% | US$ 17,64M | 2026-03-31 |
| BNP Paribas Financial Markets SNC | Institution | 303.509 | 0,71% | US$ 17,42M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
